The genetics of diabetes mellitus;A diabetes mellitus genetikája

Lege Artis Medicinae

Volumn 14, Issue 7, 2004, Pages 495-505

  Korányi, László ^a,b   Pánczél, Pál ^c  

^a DRC Kft ^*  (Hungary)

^b Drug Research Center   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Genetics; Type 1 diabetes mellitus; Type 2 diabetes mellitus

Indexed keywords

CALPAIN; CALPAIN 10; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AGE; CELL NUCLEUS; CLINICAL FEATURE; CLINICAL GENETICS; DIABETOGENESIS; DISEASE ASSOCIATION; DISEASE COURSE; ENVIRONMENTAL FACTOR; GENE EXPRESSION REGULATION; GENE ISOLATION; GENE LOCUS; GENETIC MODEL; GENETIC SUSCEPTIBILITY; HEREDITY; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; LIVER CELL; LIVER FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PATHOPHYSIOLOGY; POPULATION; PREDICTION; REVIEW;

EID: 4143072422     PISSN: 08664811     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Gale EAM. The discovery of type 1 diabetes. Diabetes 2001; 50:277-26.
2. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
3. The expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183-97.
4. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalance, numerical estimates, and projections. Diabetes Care 1998;21:1414-31.
5. Zimmet P. Burden of type 2 diabetes: are we doing enough? Diabetes Metab 2003;(4Pt2):6S9-18.
6. Moneva MH, Dagogo-Jack S. Multiple drug targets in management of type 2 diabetes. Curr Drug Targets 2002;3:203-21.
7. ADA. Type 2 diabetes in children and adolescents. Pediatrics 2000;105:671-80.
8. Kriska AM, Delahanty LM, Pettee KK. Lifestyle intervention for the prevention of type 2 diabetes: translation and future recommendations. Can Fam Physician 2003;49:1618-25.
9. Harris IB, Petrella Rj, Leadbetter W. Lifestyle interventions for type 2 diabetes. Relevance for clinical practice. Curr Diab Rep 2004; 2:113-8.
10. Douek IF, Gillespie KM, Dix RJ, Bingley PJ, Gale EAM. Three generations of autoimmune diabetes: an extended family study. Diabetologia 2003;46:1313-8.
11. Field LL. Genetic linkage and association studies of type 1 diabetes: challenges and rewards. Diabetologia 2002;45:21-35.
12. Schenker M, Hummel M, Ferber K, Walter M, Keller E, Albert ED, et al. Early expression and high prevalence of islet autoantibodies for DR3/4 heterozygous and DR4/4 homozygous offspring of parents with type 1 diabetes: the German BABYDIAB study. Diabetologia 1999;42:671-7.
13. Herman R, Gombos Zs, Gyurus É, Soltész Gy. A GAD 65 autoantitest elofordulása, prediktív értéke és összefüggése a HLA genotípussal gyermekkori 1-es típusú diabetesben. Orv Hetil 2003;144:355-60.
14. Sheehy MJ, Scarf SJ, Rowe JR. A diabetes susceptibility HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Clin Invest 1989;83:830-5.
15. Payami H, Thomson G, Motro U, Louis EJ, Hudes E. The affected sib method. IV. Sib trios. Ann Hum Genet 1985;49:303-14.
16. Pánczél P, Illyés Gy, Merétey K, Falus A, Gyódi É, Romics L, et al. Az 1-es típusú diabetes mellitus és a rheumatoid arthritis összehasonlító immunológiai vizsgálata. Orv Hetil 1986;127:2489-93.
17. Vatay Á, Rajczy K, Pozsonyi É, Hosszúfalusi N, Prohászka Z, Füst G, et al. Differences in the genetic background of latent autoimmune diabetes in adults (LADA) and type 1 diabetes mellitus. Immunology Letters 2002;84:109-15.
18. Pánczél P, Hosszúfalusi N, Bornemisza B, Horváth L, Jánoskuti L, Füst Gy, et al. A lassan kialakuló felnottkori autoimmun diabetes (LADA): az autoimmun eredetu 1-es típusú cukorbetegség klinikai spektrumának része. Orv Hetil 2001;142:2571-8.
19. Hosszúfalusi N, Vatay Á, Rajczy K, Pozsonyi É, Horváth L, Grosz A, et al. Similar genetic features and different islet-cell antibody pattern of latent autoimmune diabetes in adults (LADA) compared to adult onset type 1 diabetes mellitus with rapid progression. Diabetes Care 2003;26:452-7.
20. Bieda K, Pani MA, Van der Auwera B, Seidl C, Tönjes RR, Gorus F, et al. A retroviral long terminal repeat adjacent to the HLA DQB1 gene (DQ LTR 13) modifies type 1 diabetes susceptibility on high risk DQ haplotypes. Diabetologia 2002;45:443-7.
21. Pascual M, Koeleman BP, Eerligh P, Roep BO, Martin J. Distribution of HERV-LTR elements in HLA-DQB1 alleles. Diabetologia 2003;46:869-70.
22. Gambelunghe G, Ghaderi C, Cosentino A, et al. Association of MHC Class I chain-related A (MIC-A) gene polymorphism with type I diabetes. Diabetologia 2000;43:507-14.
23. Allock R, Cheong, F Chritiansen C, Witt C. Comment to the article Association of MHC Class I chain-related A (MIC-A) gene polymorphism with type I diabetes. Diabetologia 2001;44:514-5.
24. Weets I, Autreve J, Auwera BJ, Schuit FC, Caju MVL, Decochez K, et al. Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA DQ restricted: possible relation to increased body mass index. Diabetologia 2001;44:40-7.
25. Pani MA, Autreve J, Auwera BJ, Gorus FK, Badenhoop K. Non-transmitted maternal HLA DQ2 or DQ8 alleles and risk of type 1 diabetes in offspring: the importance of fetal or post partum exposure to diabetogenic molecules. Diabetologia 2002;45: 1340-3.
26. Bell GI, Horita S, Karam JH. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 1984;33:176-83.
27. Concannon P, Gogolin-Ewens KJ, Hinds DA. A second generation screen of the human genom for susceptibility to insulin-dependent diabetes mellitus. Nat Genet 1998;19:292-6.
28. Thomson G, Robinson WP, Kuhner MK, Joe S, Klitz W. HLA and insulin gene associations with IDDM. Genet Epidemiol 1989;6:155-60.
29. Walter M, Albert E, Conrad M, Keller E, Hummel M, Ferber K, et al. IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of type 1 diabetes and associated autoimmunity. Diabetologia 2003;46:712-20.
30. Twells RC, Metzker ML, Brown SD. The sequence and gene characterization of a 400 kb candidate region for IDDM4 on chromosome 11q13. Genomics 2001;72:231-42.
31. Kronenberg F, Auinger M, Trenkwalder E, Irsigler K, Utermann G, Dieplinger H. Is apolipoprotein(a) a susceptibility gene for type 1 diabetes mellitus and related to long-term survival? Diabetologia 1999;42:1021-7.
32. Marron MP, Raffel LJ, Garchon HJ. Insulin dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphism in multiple ethnic groups. Hum Mol Genet 1997;6:1275-82.
33. Pánczél P, Falus A, Merétey K, Romics L, Gyódi É, Vértes P, et al. 1-es típusú diabetes mellitus és reumatoid arthritis együttes családi halmozódása. Orv Hetil 1985;126:1281.
34. Becker KG. Comparative genetics of type 1 diabetes and autoimmune disease. Diabetes 1999;48:1353-8.
35. Sadeharju K, Knip M, Hiltunen M, Akerblom H, Hyöty H. The HLA DR phenotype modulates the humoral immune response to enterovirus antigens. Diabetologia 2003;46:1100-5.
36. Hermann R, Knip M, Veijola R, Siemll O, Laine AP, Akerblom HK. Temporal changes in the frequencies of HLA genotypes in patients with type 1 diabetes - indication of an increased environmental pressure. Diabetologia 2003;46:420-5.
37. Martin S, Wolf-Eichbaum D, Duinkerken G. Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency. N Engl J Med 2001;345:1036-40.
38. Schumacher MC, Hasstedt SJ, Hunt SC, Williams RR, Elbein SC. Major gene effect for insulin levels in familial NIDDM pedigrees. Diabetes 1992;41:416-23.
39. Sakul H, Pratley R, Cardon L, Ravussin E, Mott D, Bogardus C. Familiarity of physical and metabolic characteristics that predict the development on non-insulin-dependent diabetes mellitus in Pima Indians. Am J Hum Genet 1997;60:651-6.
40. Pyke DA, Theophanides CG, Tattersall RB. Genetic origin of diabetes: re-evaluation of twin data. Lancet 1976;2:464.
41. Poulsen P, Kyvik KO, Vaag A, Beck-Nielsen H. Heritability of type II diabetes mellitus and abnormal glucose tolerance- a population-based twin study. Diabetologia 1999;42:139-45.
42. Knowler WC, Pettitt DJ, Saad MF, Bennett PH. Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev 1990;6:1-27.
43. Elbein SC. Perspective: The search for genes for type 2 diabetes in the post-genome era. Endocrinology 2002;143:2012-8.
44. Schumacher MC, Hasstedt SJ, Hunt SC, Williams RR, Elbein SC. Major gene effect for insulin levels in familial NIDDM pedigrees. Diabetes 1992;41:416-23.
45. Rich SS. Mapping genes in diabetes: genetic epidemiological perspective. Diabetes 1990;39:1315-9.
46. Risch N. Searching for genetic determinants in the new millennium. Nature 2000;405:847-56.
47. Kahn CR, Vicent D, Doria A. Genetics of non-insulin-dependent (type II) diabetes mellitus. Ann Rev Med 1996;47:509-31.
48. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000;26:76-80.
49. Hanis CL, Boerwinkle E, Chakraborty R, Ellsworth DL, Concannon P, Stirling B, et al. A genomwide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 1996;13:161-6.
50. Cox NJ, Frigge M, Nicolae DL, Concannon P, Hanis CL, Bell GI, et al. Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat Genet 1999;21:213-5.
51. Duggirala R, Blangero J, Almasy L, Dyer TD, Williams KL, Leach RJ, et al. Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. Am J Hum Genet 1999;64:1127-40.
52. Ehm MG, Kamoub MC, Sakul H, Gottschalk K, Holt DC, Weber JL, et al. Genomwide search for type 2 diabetes susceptibility genes in four American populations. Am J Hum Genet 2000;66:1871-81.
53. Hanson RL, Ehm MG, Pettitt DJ, Prochazka M, Thompson DB, Timberlake D, et al. An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet 1998;63:1130-8.
54. Mahtani MM, Widen E, Lehto M, Thomas J, McCarthy M, Brayer J, et al. Mapping of a gene for type 2 diabetes associated with insulin secretion defect by a genome scan in Finnish families. Nat Genet 1996;14:90-4.
55. Lindgren CM, Mahtani MM, Widen E, McCarthy MI, Daly MJ, Kirby A, et al. Genomwide search for type 2 diabetes mellitus susceptibility loci in Finnish families: the Botnia study. Am J Hum Genet 2002;70:509-16.
56. Elbein SC, Hoffmann MD, Teng K, Leppert MF, Hasstedt SJ. A genomwide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes 1999;48:1175-82.
57. Vionnet N, Hani El H, Dupont S, Gallina S, Francke S, Dotte S, et al. Genomwide search for type diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for earlyonset diabetes on chromosome 3q27-qter and independent replication of a type 2 diabetes locus on chromosome 1q21-q24. Am J Hum Genet 2000;67:1470-80.
58. Parker A, Meyer J, Lewitzky S, Rennich JS, Chan G, Thomas JD, et al. A gene conferring susceptibility to type 2 diabetes in conjunction with obesity is located on chromosome 18p11. Diabetes 2001;50:675-80.
59. Busfield F, Duffy DL, Kesting JB, Walker SM, Lovelock PK, Good D, et al. A genomwide search for type 2 diabetes-susceptibility genes in indigenous Australians. Am J Hum Genet 2002;70:349-57.
60. Reynisdottir I, Thorleifsson G, Benediktsson R, Sigurddson G, Emilsson V, Sigurlin A, et al. Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2. Am J Hum Genet 2003;73:323-35.
61. Love-Gregory LD, Wasson J, Ma J, Jin CH, Glaser B, Suarez BK, et al. A common polymorphism in the upstream promoter region of the Hepatocyte Nuclear Factor-4alpha gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an ashkenazi jewish population. Diabetes 2004;53:1134-40.
62. Silander K, Mohlke KL, Scott LJ, Peck EC, Hollstein P, Skol AD, et al. Genetic variation near the Hepatic Nuclear Factor 4α gene predicts susceptibility to type 2 diabetes. Diabetes 2004;53:1141-9.
63. Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, et al. Control of pancreas and liver gene expression by HNF transcription factors. Science 2004;303:1378-81.
64. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000;26:163-74.
65. Baier LJ, Permana PA, Yang X, Pratley RE, Hanson RI, Shen GQ, et al. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest 2000;106:R69-R73.
66. Sreenan SK, Zhou Y-P, Otani K, Hansen PA, Currie KPM, Pan C-Y, et al. Calpains play a role in insulin secretion and action. Diabetes 2001;50:2013-20.
67. Fajans SS, Bell GI, Bowden DW, Halter JB, Polonszky KS. Maturity onset diabetes of the young (MODY). Diabet Med 1996;13:S90-S95.
68. Hertz R, Ben-Haim N, Petrescu AD, Kaldreon B, Bermman I, Eldad N, et al. Rescue of MODY-1 by agonist ligands of Hepatocyte Nuclear Factor-4α. J Biol Chem 2003;278:22578-85.
69. Koranyi LI, Tanizawa Y, Welling CM, Rabin DU, Permutt MA. Human islet glucokinase gene. Isolation and sequence analysis of full-length cDNA. Diabetes 1992;41:807.
70. Glaser B. Familiar hyperinsulinismus caused by an activating glucokinase mutation. New Engl J Med 1998;338:226-30.
71. Permutt MA, Hattersley AT. Searching for type 2 diabetes genes in the post-genom era. TEM 2000;11:383-93.
72. Sovik O, Njolstad P, Folling I, Sagen J, Cocburn BN, Bell GI. Hyperexitability to sulphanylure in MODY3. Diabetologia 1998;41:607-8.
73. Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T, et al. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet 1999;23:323-8.
74. Chan L, Fujimiya M, Kojima H. In vivo gene therapy for diabetes mellitus. TRENDS in Molecular Medicine 2003;9:430-5.